Select Medical Holdings Corporation
NYSE:SEMMedical - Care Facilities
+$0.02 today
- Market cap
- $2.05B
- Beta
- 0.79
- P/E (TTM)
- 15.3
- EPS (TTM)
- $1.08
- Dividend yield
- 1.51%
Volume 14.27M
Average 1.75M
SEM Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Select Medical Holdings CorporationNYSE: SEM
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 51.7% from a year ago
Cash & equivalents stood at $25.68M at the end of Q1 FY2026, down 51.7% from a year earlier and down 3.2% from the prior quarter. Over 3 fiscal years it compounded at -35.3% a year.
Context
- Cash & equivalents amounted to 0.4% of total assets at the end of Q1 FY2026, down 0.5 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -51.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 26.52M USD
- Year-over-year change
- -55.6%
- 4-year CAGR
- -22.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.52M | -55.6% |
| FY2024 | 2024-12-31 | 59.69M | +13.4% |
| FY2023 | 2023-12-31 | 52.63M | -46.2% |
| FY2022 | 2022-12-31 | 97.91M | +31.8% |
| FY2021 | 2021-12-31 | 74.31M | — |
Cash & Equivalents vs competitors
How SEM compares with its peers on the latest reported figures
- SEM's Mar 2026 cash & equivalents of $25.68M is the lowest of the 11 companies compared; the peer median is $211.89M.
- Its year-over-year change of -51.7% is the lowest of 11, against a peer median of +21.4%.
- Cash & equivalents amounts to 0.4% of total assets for SEM, versus a peer median of 11.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ARDTArdent Health Partners, LLC | Mar 2026 | $609.69M | +23.2% | +15.9% | 11.6% |
| Jun 2026 | $549.77M | +0.7% | +45.6% | 40.0% | |
| Mar 2026 | $478.38M | +85.0% | +14.2% | 20.3% | |
| Sep 2026 | $311.92M | -8.3% | +236.8% | 14.6% | |
| Jun 2026 | $225.94M | +19.6% | +31.8% | 10.4% | |
| Oct 2026 | $197.84M | +35.6% | +115.9% | 9.0% | |
| Sep 2026 | $163.31M | +37.6% | +10.9% | 2.9% | |
| Mar 2026 | $136.17M | +111.7% | +83.0% | 16.7% | |
| Sep 2026 | $66.8M | -48.9% | +23.7% | 3.2% | |
| Mar 2026 | $28.44M | -27.4% | +4.0% | 2.3% | |
| Mar 2026 | $25.68M | -51.7% | -35.3% | 0.4% | |
| Peer median (excluding SEM) | $211.89M | +21.4% | +27.7% | 11.0% | |
Competitors are the stored peer set for SEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 74.31M | 97.91M | 52.63M | 59.69M | 26.52M |
| Short-term Investments | 0 | 74.86M | 58.96M | 0 | 0 |
| Net Receivables | 889.3M | 941.31M | 724.14M | 821.39M | 864.21M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 120.21M | 125.37M | 407.16M | 138.7M | 134.55M |
| Total Current Assets | 1.14B | 1.27B | 1.26B | 1.02B | 1.03B |
| Property, Plant & Equipment (Net) | 2.04B | 2.17B | 1.64B | 1.78B | 1.95B |
| Goodwill | 3.45B | 3.48B | 2.28B | 2.33B | 2.36B |
| Intangible Assets | 374.88M | 351.66M | 105.15M | 103.18M | 100.8M |
| Long-term Investments | 18.06M | 45.2M | 0 | 320.9M | 346.4M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 338.67M | 341.74M | 2.41B | 51.91M | 67.99M |
| Total Non-current Assets | 6.22B | 6.39B | 6.43B | 4.59B | 4.83B |
| Total Assets | 7.36B | 7.67B | 7.69B | 5.61B | 5.85B |
| Account Payables | 233.84M | 186.73M | 153.9M | 142.16M | 157.06M |
| Short-term Debt | 59.93M | 76.31M | 99.15M | 46.07M | 229.37M |
| Tax Payables | 1.44M | 480K | 1.1M | 6.64M | 19.62M |
| Deferred Revenue | 83.79M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 271.28M | 0 | 596.83M |
| Total Current Liabilities | 1.27B | 1.16B | 1.25B | 977.65M | 984.49M |
| Long-term Debt | 3.56B | 3.84B | 3.58B | 1.69B | 2.57B |
| Deferred Tax Liabilities | 142.79M | 169.79M | 119.94M | 81.5M | 112.16M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | (10.01M) | 0 |
| Other Non-current Liabilities | 106.44M | 106.14M | 494.27M | 73.04M | (755.5M) |
| Total Non-current Liabilities | 4.72B | 5.12B | 4.87B | 2.63B | 2.83B |
| Total Liabilities | 6B | 6.27B | 6.12B | 3.61B | 3.82B |
| Common Stock | 134K | 127K | 128K | 129K | 124K |
| Retained Earnings | 593.25M | 581.01M | 751.86M | 770.15M | 837.02M |
| Accumulated OCI | 12.28M | 88.6M | 42.91M | 0 | (6.4M) |
| Other Stockholders Equity | 0 | 0 | 0 | (0) | 0 |
| Minority Interest | 254.95M | 268.69M | 285.71M | 315.74M | 330.16M |
| Total Equity | 1.36B | 1.39B | 1.57B | 2B | 2.04B |
| Total Debt | 4.76B | 5.16B | 4.52B | 2.7B | 3.7B |
| Net Debt | 4.69B | 5.06B | 4.47B | 2.64B | 3.68B |
Select Medical Holdings Corporation
NYSE:SEM
Intrinsic Alpha fair value
Locked
Current Price
$16.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.